Compare Amylx Pharmaceuticals Inc (AMLX) vs EPR Properties (EPR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs EPR Properties — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while EPR Properties trades at $59.8 (market cap $4.58B). The key difference: EPR Properties is the larger of the two by market cap, and EPR Properties pays a 6.22% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | EPR | |
|---|---|---|
Market Cap | $2.64B | $4.58B |
Sector | Health | Real Estate |
52-Week High | $24.19 | $64.32 |
52-Week Low | $7.82 | $48.71 |
Enterprise Value | $2.39B | $8.09B |
Dividend Yield | — | 6.22% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About EPR Properties
EPR Properties is a REIT specializing in experiential real estate, including movie theaters and leisure destinations like ski resorts and water parks across the US and Canada.
Read more on EPR →
